Stock Analysis·← Pickers

CCEL

Cryo-Cell International, Inc.

Cryo-Cell International, Inc. (CCEL) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 51.8, with 1/3 trend checks passing.

Price
$3.58
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
51.8
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

CCEL with MA50 and MA200

5.314.714.103.502.8907/3110/2401/2204/1707/15
CCEL2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$3.52+1.61% vs price
MA200
$3.69-3.13% vs price
RSI (14)
51.8Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
$3.41–$3.570.1% below price · 3 touches
Support Quality
3 touches0.9× zone volume
Chart Summary
Trend summary for CCEL

Cryo-Cell International, Inc. (CCEL) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $3.58, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 1.6% and below the 200-day moving average by 3.1%.

Momentum and stretch context

CCEL currently has an RSI reading of 51.8, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

This page is designed to help you quickly understand what the CCEL chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Cryo-Cell International, Inc.

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
David Portnoy
Employees
76
Market cap
$28.8M
Beta
0.57
52-week range
$2.72 – $5.43
Dividend
Yes · $0.65
Exchange
AMEX
Country
US
IPO date
4 Apr 1994
ISIN
US2288951088
CUSIP
228895108
Company profile data from Financial Modeling Prep. CCEL listed on AMEX.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about CCEL

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.